Notice: This company has been marked as potentially delisted and may not be actively trading. Fusion Pharmaceuticals (FUSN) Short Interest Ratio & Short Volume Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestTrends Fusion Pharmaceuticals Short Interest DataFusion Pharmaceuticals (FUSN) has a short interest of 3.06 million shares. This marks a -22.53% decrease in short interest from the previous month. The short interest ratio (days to cover) is 1.7, indicating that it would take 1.7 days of the average trading volume of 1.69 million shares to cover all short positions.Current Short Interest3,060,000 sharesPrevious Short Interest3,950,000 sharesChange Vs. Previous Month-22.53%Dollar Volume Sold Short$65.91 millionShort Interest Ratio1.7 Days to CoverLast Record DateMay 15, 2024Outstanding Shares85,060,000 sharesPercentage of Shares Shorted3.60%Today's Trading Volume0 sharesAverage Trading Volume1,692,620 sharesToday's Volume Vs. Average0% Short Selling Fusion Pharmaceuticals? Sign up to receive the latest short interest report for Fusion Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartFUSN Short Interest Over TimeFUSN Days to Cover Over TimeFUSN Percentage of Float Shorted Over Time Ad Porter & CompanyWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. Fusion Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/20243,060,000 shares $65.91 million -22.5%N/A1.7 $21.54 4/30/20243,950,000 shares $84.65 million -18.7%N/A2 $21.43 4/15/20244,860,000 shares $103.42 million -6.5%N/A2.3 $21.28 3/31/20245,200,000 shares $110.86 million -34.3%N/A2.4 $21.32 3/15/20247,920,000 shares $79.12 million -8.3%N/A3.6 $9.99 2/29/20248,640,000 shares $103.33 million +27.1%N/A6.9 $11.96 Get the Latest News and Ratings for FUSN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Fusion Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 2/15/20246,800,000 shares $79.70 million +62.3%N/A6 $11.72 1/31/20244,190,000 shares $48.69 million +30.9%N/A4.4 $11.62 1/15/20243,200,000 shares $28.83 million +107.8%N/A4.5 $9.01 12/31/20231,540,000 shares $14.80 million +1,618.8%N/A2.3 $9.61 12/15/202389,600 shares $470,400.00 -17.0%N/A0.2 $5.25 11/30/2023107,900 shares $597,766.00 +17.0%N/A0.5 $5.54 11/15/202392,200 shares $385,396.00 -35.9%N/A0.5 $4.18 10/31/2023143,900 shares $663,379.00 -0.4%N/A1 $4.61 10/15/2023144,400 shares $596,372.00 +42.1%N/A1 $4.13 9/30/2023101,600 shares $264,160.00 -21.1%N/A1.2 $2.60 9/15/2023128,800 shares $331,016.00 +42.2%N/A2.8 $2.57 8/31/202390,600 shares $269,988.00 -7.8%N/A1.8 $2.98 8/15/202398,300 shares $298,832.00 -2.9%N/A1.7 $3.04 7/31/2023101,200 shares $328,900.00 -17.3%N/A2 $3.25 7/15/2023122,400 shares $501,840.00 +1.9%N/A2.8 $4.10 6/30/2023120,100 shares $560,867.00 +14.9%N/A2.1 $4.67 6/15/2023104,500 shares $484,880.00 -56.8%N/A1.5 $4.64 5/31/2023241,900 shares $1.23 million -11.4%N/A3.4 $5.10 5/15/2023272,900 shares $1.25 million +1.7%N/A3.5 $4.58 4/30/2023268,300 shares $1.03 million -18.0%N/A0.8 $3.85 4/15/2023327,200 shares $1.33 million -0.1%N/A0.9 $4.06 3/31/2023327,500 shares $1.23 million +45.5%N/A0.9 $3.77 3/15/2023225,100 shares $945,420.00 No ChangeN/A0.6 $4.20 2/28/2023225,100 shares $994,942.00 -66.7%0.7%0.6 $4.42 2/15/2023675,600 shares $3.12 million +19.2%2.2%1.9 $4.62 1/31/2023566,800 shares $1.72 million -1.7%1.9%7.4 $3.03 1/15/2023576,800 shares $2.25 million +1.7%1.9%10.5 $3.90 12/30/2022567,300 shares $1.79 million -0.5%1.9%10.7 $3.15 12/15/2022570,000 shares $1.57 million -1.2%1.9%10.5 $2.76 11/30/2022576,700 shares $1.31 million +57.2%1.9%6.2 $2.27 11/15/2022366,800 shares $781,284.00 +47.3%1.2%3.9 $2.13 10/31/2022249,100 shares $610,295.00 +49.3%0.9%2.4 $2.45 10/15/2022166,900 shares $375,525.00 +133.1%0.6%1.5 $2.25 9/30/202271,600 shares $215,516.00 +92.0%0.3%0.6 $3.01Bill Gates’s Next Big AI Bet: Stargate (Ad)In February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of my favorite stocks. Shares have jumped by more than 20,000% since then.I believe we are about to do it again with this new AI project called Stargate 9/15/202237,300 shares $117,495.00 +50.4%0.1%0.3 $3.15 8/31/202224,800 shares $54,560.00 -27.5%0.1%0.4 $2.20 8/15/202234,200 shares $70,452.00 +33.6%0.1%0.7 $2.06 7/31/202225,600 shares $59,648.00 +21.3%0.1%0.9 $2.33 7/15/202221,100 shares $50,640.00 -37.2%0.1%1 $2.40 6/30/202233,600 shares $83,664.00 +6.3%0.1%1.6 $2.49 6/15/202231,600 shares $110,600.00 +4.3%0.1%1.7 $3.50 5/31/202230,300 shares $111,807.00 -62.5%0.1%2.1 $3.69 5/15/202280,800 shares $323,200.00 -4.6%0.3%2.6 $4.00 4/30/202284,700 shares $443,828.00 +16.4%0.3%2.3 $5.24 4/15/202272,800 shares $396,032.00 -3.2%0.3%1.7 $5.44 3/31/202275,200 shares $584,304.00 -1.1%0.3%1.7 $7.77 3/15/202276,000 shares $534,280.00 -11.3%0.3%1.6 $7.03 2/28/202285,700 shares $645,321.00 -8.6%0.3%1.7 $7.53 2/15/202293,800 shares $780,416.00 -1.7%0.3%2 $8.32 1/31/202295,400 shares $715,500.00 -30.3%0.3%2.6 $7.50 1/15/2022136,900 shares $903,540.00 +19.4%N/A4.2 $6.60 12/31/2021114,700 shares $478,299.00 -23.5%0.4%4.6 $4.17 12/15/2021150,000 shares $751,500.00 +4.7%0.6%6.4 $5.01 11/30/2021143,300 shares $831,140.00 +5.1%0.6%4.5 $5.80 11/15/2021136,300 shares $876,409.00 -3.3%0.6%4.4 $6.43 10/29/2021141,000 shares $988,410.00 +4.4%0.6%4 $7.01 10/15/2021135,100 shares $999,740.00 +11.6%0.6%3.2 $7.40 9/30/2021121,100 shares $959,112.00 -7.4%0.5%3 $7.92 9/15/2021130,800 shares $1.20 million -1.3%0.6%3.2 $9.19 8/31/2021132,500 shares $1.24 million -29.3%0.6%1.8 $9.33 8/13/2021187,500 shares $1.55 million +4.7%0.8%2.6 $8.24 7/30/2021179,100 shares $1.46 million +14.0%0.8%2.6 $8.15 7/15/2021157,100 shares $1.26 million -14.2%0.6%2.4 $8.05 6/30/2021183,100 shares $1.48 million -23.6%0.7%2.8 $8.08 6/15/2021239,600 shares $2.31 million -5.5%1.0%3.3 $9.64 5/28/2021253,500 shares $2.08 million +7.3%1.0%6.5 $8.21 5/14/2021236,200 shares $1.99 million +7.4%0.9%6.1 $8.42 4/30/2021219,900 shares $1.86 million +5.6%0.9%5.5 $8.47 4/15/2021208,300 shares $1.91 million -41.9%0.9%4.7 $9.17 3/31/2021358,700 shares $3.56 million +7.2%1.7%7.4 $9.93 3/15/2021334,700 shares $3.89 million -2.0%1.6%5.7 $11.63 2/26/2021341,400 shares $4.10 million +1.3%1.6%5.8 $12.00 2/12/2021337,100 shares $3.96 million -0.3%1.6%5.5 $11.75 1/29/2021338,100 shares $3.83 million -7.3%1.5%5.8 $11.32 1/15/2021364,800 shares $4.45 million No Change1.6%6.6 $12.20 FUSN Short Interest - Frequently Asked Questions What is Fusion Pharmaceuticals' current short interest? Short interest is the volume of Fusion Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of May 15th, investors have sold 3,060,000 shares of FUSN short. Learn More on Fusion Pharmaceuticals' current short interest. What is a good short interest ratio for Fusion Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. FUSN shares currently have a short interest ratio of 2.0. Learn More on Fusion Pharmaceuticals's short interest ratio. Is Fusion Pharmaceuticals' short interest increasing or decreasing? Fusion Pharmaceuticals saw a decline in short interest in May. As of May 15th, there was short interest totaling 3,060,000 shares, a decline of 22.5% from the previous total of 3,950,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Fusion Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Fusion Pharmaceuticals: Y-mAbs Therapeutics, Inc. (10.84%), MeiraGTx Holdings plc (2.56%), Arcellx, Inc. (9.74%), ADMA Biologics, Inc. (6.52%), Krystal Biotech, Inc. (12.00%), Denali Therapeutics Inc. (5.93%), Immunovant, Inc. (21.05%), CRISPR Therapeutics AG (21.78%), ImmunityBio, Inc. (33.07%), Kymera Therapeutics, Inc. (14.14%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Fusion Pharmaceuticals stock? Short selling FUSN is an investing strategy that aims to generate trading profit from Fusion Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Fusion Pharmaceuticals? A short squeeze for Fusion Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of FUSN, which in turn drives the price of the stock up even further. How often is Fusion Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including FUSN, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies Y-mAbs Therapeutics Short Interest MeiraGTx Short Interest Arcellx Short Interest ADMA Biologics Short Interest Krystal Biotech Short Interest Denali Therapeutics Short Interest Immunovant Short Interest CRISPR Therapeutics Short Interest ImmunityBio Short Interest Kymera Therapeutics Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:FUSN) was last updated on 11/13/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fusion Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fusion Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
